Comparative Efficacy and Safety Between Deferiprone and Deferasirox with Special Reference to Serum Ferritin Level and Cardiac Function in Bengali β-Thalassemia Major Children-Reference-Cited by-同舟云学术

Comparative Efficacy and Safety Between Deferiprone and Deferasirox with Special Reference to Serum Ferritin Level and Cardiac Function in Bengali β-Thalassemia Major Children

Published:2021-11-10 Issue: Volume: Page:1-7
ISSN:0363-0269
Container-title:Hemoglobin
language:en
Short-container-title:Hemoglobin

Author:

Tripathy Isita¹,Panja Amrita²^ORCID,Dolai Tuphan Kanti³,Mallick Asim Kumar¹

Affiliation:

1. Department of Paediatric Medicine, Nilratan Sircar Medical College and Hospital, Kolkata, West Bengal, India

2. Department of Zoology, Molecular Biology and Human Genetics Laboratory, The University of Burdwan, Burdwan, West Bengal, India

3. Department of Haematology, Nilratan Sircar Medical College and Hospital, Kolkata, West Bengal, India

Publisher

Informa UK Limited

Subject

Biochemistry, medical,Clinical Biochemistry,Genetics(clinical),Hematology

Link

https://www.tandfonline.com/doi/pdf/10.1080/03630269.2021.1999258

Reference29 articles.

1. β-Thalassemia

2. β-Thalassemias

3. Molecular basis and diagnosis of thalassemia

4. Discrimination of various thalassemia syndromes and iron deficiency and utilization of reticulocyte measurements in monitoring response to iron therapy

5. Guidelines on Beta-thalassemia major – regular blood transfusion therapy: Associação Brasileira de Hematologia, Hemoterapia e Terapia Celular: project guidelines: Associação Médica Brasileira – 2016

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Differential effects of iron chelators on iron burden and long-term morbidity and mortality outcomes in a large cohort of transfusion-dependent β-thalassemia patients who remained on the same monotherapy over 10 years;Blood Cells, Molecules, and Diseases;2024-07

2. Understanding the Intricacies of Iron Overload Associated with β-Thalassemia: A Comprehensive Review;Thalassemia Reports;2023-07-03

3. Interventions for improving adherence to iron chelation therapy in people with sickle cell disease or thalassaemia;Cochrane Database of Systematic Reviews;2023-03-06

4. No difference in myocardial iron concentration and serum ferritin with deferasirox and deferiprone in pediatric patients with hemoglobinopathies: A systematic review and meta-analysis;Transfusion Clinique et Biologique;2023-02

5. The Value of SIRT1/FOXO1 Signaling Pathway in Early Detection of Cardiovascular Risk in Children with β-Thalassemia Major;Biomedicines;2022-10-17